Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Bronchopulmonary Dysplasia (BPD): early-phase trial registry

2 of 6 indexed Bronchopulmonary Dysplasia (BPD) trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Bronchopulmonary Dysplasia (BPD): 6 US clinical trials tracked, 2 recruiting.

Bronchopulmonary Dysplasia (BPD) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is NICHD Neonatal Research Network, running 3 of these trials.

Enrollment posture brief

Registry condition bronchopulmonary-dysplasia-bpd

OPEN 2 | RECR 33% | LATE 1 | EARLY 2 | RANK #2866 | SPON 3

Volume-matched condition peers

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Bronchopulmonary Dysplas (th…33%
Open-enrollment share among volume-matched conditions near Bronchopulmonary Dysplasia (BPD)

Bronchopulmonary Dysplasia (BPD) lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Bronchopulmonary Dysplasia (BPD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Bronchopulmonary Dysplasia (BPD) is recruiting below its size-band peers.

    2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Bronchopulmonary Dysplasia (BPD) research.

    NICHD Neonatal Research Network accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Bronchopulmonary Dysplasia (BPD) enrolment sits around 410 participants.

    Median target enrolment is 410 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.

  4. Bronchopulmonary Dysplasia (BPD) splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 31

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 1

Top Sponsors

NICHD Neonatal Research Network 3 trials
Medical College of Wisconsin 1 trials
Duke University 1 trials
Stanford University 1 trials

Named interventions

Most-linked intervention names on Bronchopulmonary Dysplasia (BPD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Restricted red cell transfusion Procedure
1 trials
Liberal Cell Transfusion Procedure
1 trials
surfactant (poractant alfa;Curosurf) Drug
1 trials
budesonide (Pulmicort nebulizing suspension). Drug
1 trials
Metformin (open-label) Drug
1 trials
montelukast 4 mg granule Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Bronchopulmonary Dysplasia (BPD) trials. A trial with sites in several states counts in each.

North Carolina 4 trials
California 4 trials
Texas 3 trials
Rhode Island 3 trials
Ohio 3 trials
New York 3 trials
New Mexico 3 trials
Iowa 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Bronchopulmonary Dysplasia (BPD) page

6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Bronchopulmonary Dysplasia (BPD) condition card totals 6 registered trials; most-linked intervention Restricted red cell transfusion; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.